Sjögren's syndrome-associated interstitial lung disease: A multicenter study
- PMID: 26573882
- DOI: 10.1016/j.reuma.2015.09.003
Sjögren's syndrome-associated interstitial lung disease: A multicenter study
Abstract
Primary Sjögren syndrome (PSS) is a chronic inflammatory autoimmune disease. Interstitial lung disease (ILD) can be an extraglandular complication.
Objective: To evaluate the clinical characteristics of patients diagnosed with PSS with ILD.
Methods: Multicentre cohort study with 25 patients diagnosed with PSS and ILD. Data of PSS, prognostic factors, pulmonary involvement variables, complementary tests that suggest a worse diagnosis and treatment given were collected. EULAR index was measured for Sjögren's syndrome.
Results: We identified 25 patients. In 15/25 the diagnosis of ILD was done before the diagnosis of PSS. The histopathological patterns found were: 12 NSIP, 5 UIP, 4 OP, 2 LIP. PFRs showed restrictive pattern. The majority of the patients received glucocorticoid therapy, antimalarial or immunosuppressive treatment.
Conclusions: Patients affected with PSS must be screened to catch a precocious diagnosis of ILD. The majority of the patients were diagnosed of ILD before being diagnosed of PSS. Multicenter cohorts are increasingly demanded and a multidisciplinary management is needed.
Keywords: Enfermedad pulmonar intersticial; Interstitial lung disease; Sjögren syndrome; Síndrome de Sjögren.
Copyright © 2015 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.
Similar articles
-
Prognostic factors in interstitial lung disease associated with primary Sjögren's syndrome: a retrospective analysis of 33 pathologically-proven cases.PLoS One. 2013 Sep 9;8(9):e73774. doi: 10.1371/journal.pone.0073774. eCollection 2013. PLoS One. 2013. PMID: 24040065 Free PMC article.
-
A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population.Clin Rheumatol. 2018 Nov;37(11):2981-2988. doi: 10.1007/s10067-018-4289-6. Epub 2018 Sep 22. Clin Rheumatol. 2018. PMID: 30242640
-
Glandular involvement in primary Sjögren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study.Clin Exp Rheumatol. 2022 Dec;40(12):2344-2349. doi: 10.55563/clinexprheumatol/7bylp2. Epub 2022 Nov 30. Clin Exp Rheumatol. 2022. PMID: 36533977
-
Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjӧgren's syndrome: A systematic review from the Italian Society of Rheumatology.Autoimmun Rev. 2020 Feb;19(2):102447. doi: 10.1016/j.autrev.2019.102447. Epub 2019 Dec 14. Autoimmun Rev. 2020. PMID: 31843713
-
Interstitial lung disease in Sjögren's syndrome: a clinical review.Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):291-300. Epub 2020 Oct 23. Clin Exp Rheumatol. 2020. PMID: 33095142 Review.
Cited by
-
Pulmonary Manifestations of Primary Sjögren's Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management.Front Immunol. 2019 Jun 12;10:1327. doi: 10.3389/fimmu.2019.01327. eCollection 2019. Front Immunol. 2019. PMID: 31249572 Free PMC article. Review.
-
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease.Drugs Context. 2021 Jan 15;10:2020-8-7. doi: 10.7573/dic.2020-8-7. eCollection 2021. Drugs Context. 2021. PMID: 33505478 Free PMC article. Review.
-
A Practical Multidisciplinary Approach to Identifying Interstitial Lung Disease in Systemic Autoimmune Rheumatic Diseases: A Clinician's Narrative Review.Diagnostics (Basel). 2024 Nov 27;14(23):2674. doi: 10.3390/diagnostics14232674. Diagnostics (Basel). 2024. PMID: 39682582 Free PMC article. Review.
-
Performance of the 2016 ACR-EULAR classification criteria for primary Sjogren's syndrome in a Korean cohort.Rheumatol Int. 2018 Sep;38(9):1651-1660. doi: 10.1007/s00296-018-4109-y. Epub 2018 Jul 20. Rheumatol Int. 2018. PMID: 30030624
-
Risk factors for progression of interstitial lung disease in Sjögren's syndrome: a single-centered, retrospective study.Clin Rheumatol. 2022 Apr;41(4):1153-1161. doi: 10.1007/s10067-021-05984-1. Epub 2021 Nov 10. Clin Rheumatol. 2022. PMID: 34757493
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous